TY - JOUR
T1 - Competitive binding to the cytosolic 2,3,7,8-tetrachlorodibenzo-p-dioxin receptor. Effects of structure on the affinities of substituted halogenated biphenyls-A QSAR analysis
AU - Bandiera, Stelvio
AU - Sawyer, Thomas W.
AU - Campbell, Mary Anne
AU - Toshio, Fujita
AU - Safe, Stephen
N1 - Funding Information:
Acknowledgements-The authors thank Lorna Safe and Marjorie Romkes for their technicala ssistancea nd Linda Bessiref or secretariahl elp in the preparationo f the manuscript. This investigationw as supportedb y financiala ssist-ancef rom the Natural Sciencesa nd EngineeringR esearch Council of Canadaa nd the Texas AgriculturalE xperiment Station (Project No. 6376).
Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1983/12/15
Y1 - 1983/12/15
N2 - The proposed mechanism of action of the toxic halogenated aromatics, typified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), involves the initial binding to a high-affinity, low-capacity, cytosolic receptor protein. Previous studies have shown that several 4'-halo-2,3,4,5-tetrachlorobiphenyls bind to the TCDD receptor and that a lateral substituent on both phenyl rings is required for activity. Using an extended series of eighteen 4'-substituted-2,3,4,5-tetrachlorobiphenyls as probes, the effects of a variable lateral substituent on receptor binding affinity and the induction of aryl hydrocarbon hydroxylase (AHH) in vivo and in rat hepatoma H-4-II E cells have been determined. For most substituents, there was an excellent correlation between the rank-order potency for receptor binding and the rank-order potency for AHH induction. Based on in vitro binding affinities (ec50 values) of the 4'-substituted tetrachlorobiphenyls, a multiparameter regression equation was formulated correlating the binding constants to physicochemical substituent parameters. For thirteen compounds out of the present series, multiple regression analysis of the binding data led to the following equation: log(1/ec50) = 1.530σ + 1.47π + 1.09HB + 4.08, r = 0.978. The results suggest that halogen substitution on both phenyl rings is not a requirement for binding and that hydrophobic (π) and electronic (σ) substituent constants and a variable for hydrogen bond (HB) formation are significant parameters describing relative binding avidities of this series of substituted biphenyls for the TCDD receptor.
AB - The proposed mechanism of action of the toxic halogenated aromatics, typified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), involves the initial binding to a high-affinity, low-capacity, cytosolic receptor protein. Previous studies have shown that several 4'-halo-2,3,4,5-tetrachlorobiphenyls bind to the TCDD receptor and that a lateral substituent on both phenyl rings is required for activity. Using an extended series of eighteen 4'-substituted-2,3,4,5-tetrachlorobiphenyls as probes, the effects of a variable lateral substituent on receptor binding affinity and the induction of aryl hydrocarbon hydroxylase (AHH) in vivo and in rat hepatoma H-4-II E cells have been determined. For most substituents, there was an excellent correlation between the rank-order potency for receptor binding and the rank-order potency for AHH induction. Based on in vitro binding affinities (ec50 values) of the 4'-substituted tetrachlorobiphenyls, a multiparameter regression equation was formulated correlating the binding constants to physicochemical substituent parameters. For thirteen compounds out of the present series, multiple regression analysis of the binding data led to the following equation: log(1/ec50) = 1.530σ + 1.47π + 1.09HB + 4.08, r = 0.978. The results suggest that halogen substitution on both phenyl rings is not a requirement for binding and that hydrophobic (π) and electronic (σ) substituent constants and a variable for hydrogen bond (HB) formation are significant parameters describing relative binding avidities of this series of substituted biphenyls for the TCDD receptor.
UR - http://www.scopus.com/inward/record.url?scp=0021048670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021048670&partnerID=8YFLogxK
U2 - 10.1016/0006-2952(83)90153-3
DO - 10.1016/0006-2952(83)90153-3
M3 - Article
C2 - 6318772
AN - SCOPUS:0021048670
SN - 0006-2952
VL - 32
SP - 3803
EP - 3813
JO - Biochemical pharmacology
JF - Biochemical pharmacology
IS - 24
ER -